Abstract
There is now a huge need to innovate, design and use novel and practicable rapid diagnostic assays (RDA) to combat the grave challenge of emerging life-threatening and multiple drug resistant bacteria (MDR) bacterial pathogens. The conventional methods of diagnosing bacterial pathogens are well enough to give good specificity. However, the sensitivity of assays in terms of short time is still not well settled. The increased population of the world along with availability of global transport means resulted in the emergence of critical health situations that the current time-consuming means of diagnosis cannot cope with the timely management of diseases caused by serious human pathogens.